Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

942 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
Tang LQ, Chen DP, Guo L, Mo HY, Huang Y, Guo SS, Qi B, Tang QN, Wang P, Li XY, Li JB, Liu Q, Gao YH, Xie FY, Liu LT, Li Y, Liu SL, Xie HJ, Liang YJ, Sun XS, Yan JJ, Wu YS, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Lv X, Wang L, Xia WX, Zhao C, Cao KJ, Qian CN, Guo X, Hong MH, Nie ZQ, Chen QY, Mai HQ. Tang LQ, et al. Among authors: li y, li xy, li jb. Lancet Oncol. 2018 Apr;19(4):461-473. doi: 10.1016/S1470-2045(18)30104-9. Epub 2018 Feb 28. Lancet Oncol. 2018. PMID: 29501366 Clinical Trial.
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Xiao BB, Chen QY, Sun XS, Li JB, Luo DH, Sun R, Lin DF, Zhang X, Fan W, Lv XF, Han LJ, Wen YF, Yuan L, Guo SS, Liu LT, Liu SL, Tang QN, Liang YJ, Li XY, Lin C, Guo L, Mai HQ, Tang LQ. Xiao BB, et al. Among authors: li xy, li jb. Eur Radiol. 2021 Jul;31(7):5222-5233. doi: 10.1007/s00330-020-07478-1. Epub 2021 Jan 8. Eur Radiol. 2021. PMID: 33416977 Free PMC article.
Development and validation of a normal tissue complication probability model for acquired nasal cavity stenosis and atresia after radical radiotherapy for nasopharyngeal carcinoma.
Yan JJ, Guo SS, Lin DF, Liu LT, Liu SL, Xiao BB, Yang JH, Wen DX, Yang ZC, Liang YJ, Tang QN, Lin C, Li XY, Sun XS, Li JB, Tang LQ, Chen QY, Mai HQ. Yan JJ, et al. Among authors: li xy, li jb. Radiother Oncol. 2021 Jul;160:9-17. doi: 10.1016/j.radonc.2021.03.040. Epub 2021 Apr 9. Radiother Oncol. 2021. PMID: 33839205 Free article.
Comparison and quantification of different concurrent chemotherapy regimens with radiotherapy in locally advanced non-small cell lung cancer: Clinical outcomes and theoretical results from an extended LQ and TCP model.
Ai X, Qiu B, Zhou Y, Li S, Li Q, Huan J, Li J, Hu N, Chen N, Liu F, Wang D, Chu C, Wang B, Chen L, Jiang H, Huang S, Huang X, Bi N, Liu H. Ai X, et al. Radiother Oncol. 2022 Feb;167:34-41. doi: 10.1016/j.radonc.2021.11.033. Epub 2021 Dec 7. Radiother Oncol. 2022. PMID: 34890734
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.
Tang LL, Huang CL, Zhang N, Jiang W, Wu YS, Huang SH, Mao YP, Liu Q, Li JB, Liang SQ, Qin GJ, Hu WH, Sun Y, Xie FY, Chen L, Zhou GQ, Ma J. Tang LL, et al. Among authors: li jb. Lancet Oncol. 2022 Apr;23(4):479-490. doi: 10.1016/S1470-2045(22)00058-4. Epub 2022 Feb 28. Lancet Oncol. 2022. PMID: 35240053 Clinical Trial.
Adjuvant Apatinib in Nasopharyngeal Carcinoma With Residual Epstein-Barr Virus DNA After Radiation Therapy: A Biomarker-Driven, Phase 2 Trial.
Liu X, Guo L, Xie FY, Hu WH, Chen MY, He QM, Xu ZM, Zhang CQ, Peng YL, Tang LL, Mao YP, Sun R, Li JB, Argiris A, Hui EP, Sun Y, Ma J. Liu X, et al. Among authors: li jb. Int J Radiat Oncol Biol Phys. 2022 Aug 1;113(5):1063-1071. doi: 10.1016/j.ijrobp.2022.04.049. Epub 2022 May 9. Int J Radiat Oncol Biol Phys. 2022. PMID: 35550406 Clinical Trial.
Medial retropharyngeal nodal region sparing radiotherapy versus standard radiotherapy in patients with nasopharyngeal carcinoma: open label, non-inferiority, multicentre, randomised, phase 3 trial.
Mao YP, Wang SX, Gao TS, Zhang N, Liang XY, Xie FY, Zhang Y, Zhou GQ, Guo R, Luo WJ, Li YJ, Liang SQ, Lin L, Li WF, Liu X, Xu C, Chen YP, Lv JW, Huang SH, Liu LZ, Li JB, Tang LL, Chen L, Sun Y, Ma J. Mao YP, et al. Among authors: li wf, li yj, li jb. BMJ. 2023 Feb 6;380:e072133. doi: 10.1136/bmj-2022-072133. BMJ. 2023. PMID: 36746459 Free PMC article. Clinical Trial.
942 results